ALX Oncology
ALXO
#8908
Rank
NZ$0.17 B
Marketcap
$3.31
Share price
15.43%
Change (1 day)
-86.17%
Change (1 year)

Earnings for ALX Oncology (ALXO)

Earnings in 2024 (TTM): -NZ$0.25 Billion

According to ALX Oncology's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$0.29 Billion a decrease over its 2022 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ALX Oncology from 2019 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.25 Billion-14.33%
2023 -NZ$0.29 Billion27.41%
2022 -NZ$0.23 Billion49.61%
2021 -NZ$0.15 Billion86.94%
2020 -NZ$79.21 Million132.9%
2019 -NZ$34.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion-9.83%๐Ÿ‡บ๐Ÿ‡ธ USA